EG 427
Startup
EG 427
Description
EG 427 develops precision molecular therapies designed for tackling, in a safe and durable way, chronic diseases at their local root.
EG 427
Address
29 RUE DU FAUBOURG SAINT JACQUES PARIS 75014
France
France
Contact
Description
EG 427 develops precision molecular therapies designed for tackling, in a safe and durable way, chronic diseases at their local root.
Matchmaking
Connect with EG 427
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways